Chinese drug regulator fines Changsheng Bio-Tech unit over vaccine scandal

China's drug regulator imposed penalties on a unit of Changsheng Bio-Technology worth 9.1 billion yuan ($1.3 billion) over a vaccine scandal, Xinhua news agency said on Tuesday.